triazoles has been researched along with Diabetic Retinopathy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, H; Tang, L; Wu, W; Xia, X; Xu, H; Yao, F | 1 |
| Been, JH; Cho, J; Choi, K; Choi, S; Choi, SW; Han, J; Jiang, W; Kim, D; Kim, KL; Kim, S; Lee, SK; Oh, J; Park, C; Seo, S; Suh, W | 1 |
| Ambrósio, AF; Fernandes, R; Gonçalves, A; Leal, E; Marques, C; Reis, F; Ribeiro, CF | 1 |
| Nie, J; Wang, F; Wang, H; Zhang, C | 1 |
| Ambrósio, AF; Fernandes, R; Gonçalves, A; Leal, E; Paiva, A; Reis, F; Ribeiro, CF; Teixeira Lemos, E; Teixeira, F | 1 |
| de la Cruz, JP; García-Campos, J; Moreno, A; Ruiz-Ruiz, MI; Sánchez de la Cuesta, F | 1 |
1 review(s) available for triazoles and Diabetic Retinopathy
| Article | Year |
|---|---|
Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
Topics: Animals; Blood-Retinal Barrier; Diabetic Retinopathy; Erythropoietin; Fenofibrate; Humans; Insulin-Like Growth Factor Binding Protein 3; Macular Edema; Protective Factors; Pyrazines; Sitagliptin Phosphate; Triazoles; Vascular Endothelial Growth Factor A | 2014 |
5 other study(ies) available for triazoles and Diabetic Retinopathy
| Article | Year |
|---|---|
Normal vitreous promotes angiogenesis via activation of Axl.
Topics: Animals; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; CRISPR-Cas Systems; Diabetic Retinopathy; Enzyme Activation; HEK293 Cells; Humans; Mice; Neovascularization, Pathologic; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Retinal Vessels; Triazoles; Vitreoretinopathy, Proliferative; Vitreous Body | 2021 |
Discovery of Novel Small-Molecule Antiangiogenesis Agents to Treat Diabetic Retinopathy.
Topics: Angiogenesis Inhibitors; Angiopoietin-2; Animals; Cell Survival; Diabetic Retinopathy; Disease Models, Animal; Down-Regulation; Drug Design; Drug Stability; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Phosphatidylinositol 3-Kinases; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Triazoles | 2021 |
Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Topics: Animals; Apoptosis; Biomarkers; Blood-Retinal Barrier; Blotting, Western; Cell Death; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Enzyme-Linked Immunosorbent Assay; Immunoenzyme Techniques; Inflammation; Male; Neurons; Pyrazines; Rats; Rats, Wistar; Retina; Sitagliptin Phosphate; Triazoles | 2014 |
Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model.
Topics: Animals; Apoptosis; Blood-Retinal Barrier; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Immunohistochemistry; In Situ Nick-End Labeling; Male; Pyrazines; Rats; Rats, Zucker; Sitagliptin Phosphate; Triazoles | 2012 |
Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
Topics: Analysis of Variance; Animals; Azepines; Blood Glucose; Blood Platelets; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Epoprostenol; Lipid Peroxidation; Male; Neovascularization, Pathologic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Retina; Thromboxane B2; Triazoles | 1998 |